April 28, 2010 |
For the first time in a quarter of a century, researchers have identified a new treatment for diabetic macular edema, a potentially blinding disorder that affects about 1 million Americans, researchers said Tuesday. The treatment uses a drug called ranibizumab, which when administered in combination with laser phototherapy is twice as effective at reversing vision loss as laser therapy alone. Laser therapy to prevent leakage of blood vessels in the retina has been the gold standard since it was introduced in 1985.
CALIFORNIA | LOCAL
May 15, 2010 |
The first-of-its kind stem cell research facility opened Friday at UC Irvine, with leading scientists and state officials on hand to do the honors. UC Irvine's Sue and Bill Gross Hall: A California Institute for Regenerative Medicine is the first of seven such facilities the state agency plans to open for stem cell research at California universities. The statewide regenerative medicine agency was created after passage of Proposition 71 in 2004 by 59% of voters, who supported new funding sources for stem cell research after then-President George W. Bush banned federal funding to develop new stem cell lines.
June 21, 1999
Thank you for informing the public about macular degeneration ("Talking About Degeneration," June 7), the leading cause of vision loss in older adults. The Center for the Partially Sighted is one of the local agencies addressing this issue. We would like to offer a few additional points about macular degeneration: Smoking and exposure to sunlight have been found to increase the risk; diets rich in leafy green and most colorful vegetables and fruits may be helpful in reducing the risk of developing macular degeneration.
July 14, 2011 |
After more than 20 years of research, doctors at UCLA's Jules Stein Eye Institute have begun treating the first patients in clinical trials for two progressive eye diseases that cause blindness: dry age-related macular degeration and Stargardt's macular dystrophy. For the Record, 12:27 p.m. July 26: An earlier version of this post had an incorrect age for the patient with Stargardt's macular degeneration. She is actually older, according to UCLA officials, though they declined to give her exact age. Also, in the original post Stargardt's was misspelled once as Stardgart's.
January 3, 2011 |
A therapy derived from human embryonic stem cells may help millions of Americans battle a common form of blindness. Advanced Cell Technology Inc. said Monday that it has received a green light from the U.S. Food and Drug Administration to begin a clinical trial to test its therapeutic cells as a treatment for dry age-related macular degeneration. The company plans to enroll a dozen patients in a Phase I/II trial, which would primarily test the safety of the cells and whether they are well-tolerated by patients.
February 20, 2012 |
British actress Judi Dench is seeking to downplay fears over the revelation that she is suffering from a degenerative eye condition. The Oscar-winning Dench, perhaps best known as James Bond's mysterious boss M, has been dealing with two different forms of macular generation -- one in each eye. According to Reuters, she can no longer read scripts and has to have someone read them out loud to her, "like reading me a story. " According to the National Eye Institute, macular degeneration occurs in an area known as the macula, which sits at the center of the light-sensitive tissue known as the retina, located at the back of the eye socket.